MRT(MRT)
MRT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $76M | $117M |
| Low | $76M | $99M |
| High | $76M | $136M |
| EBITDA Avg | $-46M | $-70M |
| Low | $-46M | $-81M |
| High | $-45M | $-59M |
| EBIT Avg | $-60M | $-92M |
| Low | $-60M | $-106M |
| High | $-59M | $-77M |
| Net Income Avg | $-19M | $-4M |
| Low | $-21M | $-5M |
| High | $-16M | $-4M |
| EPS Avg | $-0.24 | $-0.06 |
| Low | $-0.27 | $-0.06 |
| High | $-0.20 | $-0.05 |
| Analysts (Rev / EPS) | 2 / 1 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $24M | $26M | $27M | $30M | $33M | $32M |
| Low | $24M | $25M | $26M | $29M | $33M | $32M |
| High | $25M | $26M | $27M | $30M | $34M | $33M |
| EBITDA Avg | $-14M | $-15M | $-16M | $-18M | $-20M | $-19M |
| Low | $-15M | $-16M | $-16M | $-18M | $-20M | $-20M |
| High | $-14M | $-15M | $-16M | $-18M | $-19M | $-19M |
| EBIT Avg | $-19M | $-20M | $-21M | $-23M | $-26M | $-25M |
| Low | $-19M | $-21M | $-21M | $-24M | $-26M | $-26M |
| High | $-19M | $-20M | $-21M | $-23M | $-26M | $-25M |
| Net Income Avg | $-3M | $-3M | $-3M | $-860,427 | $860,427 | $-2M |
| Low | $-4M | $-4M | $-3M | $-880,479 | $840,375 | $-2M |
| High | $-3M | $-3M | $-3M | $-840,375 | $880,479 | $-2M |
| EPS Avg | $-0.04 | $-0.04 | $-0.03 | $-0.01 | $0.01 | $-0.02 |
| Low | $-0.04 | $-0.04 | $-0.03 | $-0.01 | $0.01 | $-0.02 |
| High | $-0.04 | $-0.04 | $-0.03 | $-0.01 | $0.01 | $-0.02 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |